Pharmaceuticals
WHY AND HOW WE USE NEUTRONS?
CASE STUDIES
"Neutrons have proven themselves to be a key resource for this project; we needed to analyse the p7 protein structure in a specific environment. Now we can take this deep understanding of the virus not only to devices like biosensors, but also to other fields, to study the behaviour of membrane proteins in lipid bilayers, for example.” Bruno Tillier, Managing Director, Synthelis
TECHNIQUES RELEVANT TO THE FIELD
PRICE EXAMPLES
Prices can vary depending on the complexity of the measurement
- SANS data: from 150 EUR/sample
- Identification of crystalline planes (Laue diffraction pattern): from 100 EUR/sample
- In-situ (temperature, pressure) diffraction data: from 6 kEUR
NEWS CORNER
- News,Health,Chemistry,Industry - Pharmaceuticals,Scientific news,D16
- News,Industry,Industry - Pharmaceuticals,General news
- Industry - Pharmaceuticals,General news,France,Switzerland
- Health,Biology Health,Industry - Pharmaceuticals,Scientific news,D22,FIGARO,Austria,France,Italy,Sweden
- News,Health,Biology Health,Industry - Pharmaceuticals,Scientific news,D11
- News,Health,Biology Health,Industry - Pharmaceuticals,Scientific news,D22,Sweden,United Kingdom
- News,Health,Industry - Pharmaceuticals,Scientific news,FIGARO
- Environment,Industry - Pharmaceuticals,Scientific news,D50-NeXT,Germany
- Health,Biology Health,Industry - Pharmaceuticals,Soft matter,Scientific news,IN13,IN16B,France,Italy
- News,Biology Health,Industry - Pharmaceuticals,Scientific news,DALI,LADI-III,USA